We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
(+11%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$141M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$96.6M |
| 4 |
Amazon
AMZN
|
+$63.7M |
| 5 |
Prologis
PLD
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$56.3M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$36M |
| 3 |
Y
Alleghany Corp
Y
|
+$33M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$26.6M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 14.94% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 10% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KALV
2726
DELISTED
KalVista Pharmaceuticals
KALV
| $254K | ﹤0.01% |
37,585
+72
| +0.2% | +$386 |
|
|
KLRS
2727
Kalaris Therapeutics
KLRS
$96.8M
| $254K | ﹤0.01% |
2,157
+83
| +4% | +$14.1K |
|
2728
Rocky Brands
RCKY
$369M
| $252K | ﹤0.01% |
10,681
+373
| +4% | +$8.64K |
|
|
IGMS
2729
DELISTED
IGM Biosciences
IGMS
| $251K | ﹤0.01% |
14,731
+491
| +3% | +$9.82K |
|
2730
Energy Vault
NRGV
$633M
| $250K | ﹤0.01% |
80,150
+15,050
| +23% | +$55.8K |
|
2731
ESS Tech
GWH
$18.9M
| $249K | ﹤0.01% |
6,832
+122
| +2% | +$6.26K |
|
2732
Ramaco Resources Class A
METC
$649M
| $248K | ﹤0.01% |
29,108
+594
| +2% | +$6K |
|
2733
NextDecade
NEXT
$1.78B
| $247K | ﹤0.01% |
49,909
+5,337
| +12% | +$30.7K |
|
2734
Wheels Up
UP
$198M
| $247K | ﹤0.01% |
1,201
+18
| +2% | +$4.64K |
|
2735
Quantum-Si Incorporated
QSI
$177M
| $246K | ﹤0.01% |
134,614
+2,018
| +2% | +$5.2K |
|
|
FREE
2736
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $246K | ﹤0.01% |
60,363
+1,025
| +2% | +$3.73K |
|
2737
908 Devices
MASS
$364M
| $243K | ﹤0.01% |
31,936
+599
| +2% | +$7.25K |
|
|
DNMR
2738
DELISTED
Danimer Scientific, Inc.
DNMR
| $243K | ﹤0.01% |
3,399
+60
| +2% | +$5.68K |
|
2739
Distribution Solutions Group
DSGR
$1.61B
| $242K | ﹤0.01% |
+13,134
| New | +$221K |
|
2740
FS KKR Capital
FSK
$3.44B
| $240K | ﹤0.01% |
13,733
| – | – |
|
|
FIRY
2741
Firy Inc
FIRY
$163M
| $240K | ﹤0.01% |
23,623
-67
| -0.3% | -$1.23K |
|
2742
Rimini Street
RMNI
$471M
| $239K | ﹤0.01% |
62,741
+2,003
| +3% | +$8.89K |
|
2743
Aura Biosciences
AURA
$826M
| $238K | ﹤0.01% |
22,670
+331
| +1% | +$4.21K |
|
2744
First Watch Restaurant Group
FWRG
$766M
| $238K | ﹤0.01% |
17,611
+4,022
| +30% | +$61.3K |
|
2745
Silvercrest Asset Management
SAMG
$79.9M
| $238K | ﹤0.01% |
12,680
-6
| -0% | -$108 |
|
|
YMAB
2746
DELISTED
Y-mAbs Therapeutics
YMAB
| $238K | ﹤0.01% |
48,749
+1,944
| +4% | +$14.1K |
|
2747
Oportun Financial
OPRT
$372M
| $237K | ﹤0.01% |
42,971
+1,054
| +3% | +$5.51K |
|
|
WHWK
2748
Whitehawk Therapeutics
WHWK
$271M
| $237K | ﹤0.01% |
18,489
+424
| +2% | +$5.54K |
|
2749
Alico
ALCO
$283M
| $235K | ﹤0.01% |
9,852
+159
| +2% | +$4.6K |
|
2750
Blue Bird Corp
BLBD
$2.18B
| $234K | ﹤0.01% |
21,831
+736
| +3% | +$7.39K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.
- RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
- RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
- RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
- RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
- RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
- RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.